Customers tell us they want peace of mind so that if a consumer has their beverage across multiple day parts, they will have a large margin before hitting tolerance levels. Why beverage brands need to brace themselves The thirst for GLP-1 medication only looks set to increase among consumers with the launch of unfussy, non-injectable formats A pill version of the appetite-suppressing drug, Wegovy, was unveiled by pharma giant Novo Nordisk in January Eli Lilly & Co is preparing to debut its own oral version, Orforglipron, post-FDA approval later this year The total GLP-1 pill market is forecast to leap from $3.2bn in 2025 to 34.3 bn in 2031, a CAGR of 48.4% (GlobalData) (Source GlobalData) GLP-1 drink NPD outside the box Although, its not just traditional food and beverage companies developing tailored NPD
This supplement is ideal for active individuals and athletes looking for a stimulant-free way to support their metabolism, endurance, and recovery
Storage requirements for the lyophilized powder form is 2-8C in dry conditions, reconstituted solutions are stable for up to 30 days under refrigeration
Left alone in their natural habitat, they can live much longer than that
The FDA website (www.fda.gov.ph) has a Search feature which may be used by typing in the name of the product before purchasing
3 6